2-(2-Chloro-4,6-difluorophenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 95%, 250mg

1-((2-isopropyl-5-methylcyclohexyl)oxy)-3-(isopropylamino)propan-2-ol hydrochloride, 95.0%, 500mg

1,7-Dihydro-dipyrrolo[2,3-b:3',2'-e]pyridine, 98%, 250mg

Azelaic acid, min. 80%, 25 g, plastic packaging.

2-(4-(thien-2-yl)phenyl)thiophene, 95.0%, 250mg

ethyl 2-hydroxy-4-oxo-4-[3-(trifluoromethyl)phenyl]but-2-enoate, 95%, 1g

6-Chloro-1H-indazole-3-carboxylic acid, 95.0%, 1g

2,3-Dibromo-6-chloropyridine, 95.0%, 25g

ethyl 3-[(4-phenylbutan-2-yl)amino]propanoate, 95.0%, 2g

2-((tert-Butoxycarbonyl)amino)-4-methylpyrimidine-5-carboxylic acid, 500mg

1,5-Dibromo-2-methoxy-3-(trifluoromethyl)benzene, 98%, 500mg

2-(4-Methylpiperidin-1-yl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrimidine, 98%, 250mg

2,3-Difluoroanisole, 98.0%, 1g